536
$50M$100M
66
71$10M$50M
70$10M$50M
2$10M
158$10M$50M
295$50M$100M
54$10M
188$10M$50MOrum Therapeutics uses 8 technology products and services including Google Analytics, Squarespace, Stimulus, and more. Explore Orum Therapeutics's tech stack below.
| Orum Therapeutics Email Formats | Percentage |
| First.Last@orumrx.com | 48% |
| LFirst@orumrx.com | 2% |
| First.Last@orumrx.com | 48% |
| LFirst@orumrx.com | 2% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
Orum Therapeutics is an oncology-focused, private, clinical stage biotech pioneering the development of antibody-enabled, dual-precision targeted protein homeostasis. We leverage our TPD² approach to provide targeted protein degraders, and TPS² approach to provide targeted protein stabilizers for cell-specific delivery to improve patient outcomes. Orum is located in Lexington, MA, USA and Daejeon, South Korea.
Company Overview
Media & News
Funding & FinancialsOrum Therapeutics has raised a total of $122M of funding over 3 rounds. Their latest funding round was raised on Jun 23, 2021 in the amount of $84Mas a Series B.
Orum Therapeutics's revenue is in the range of $10M
Funding & FinancialsOrum Therapeutics has raised a total of $122M of funding over 3 rounds. Their latest funding round was raised on Jun 23, 2021 in the amount of $84Mas a Series B.
Orum Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com